UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces

Infection and immunity, 2001-05, Vol.69 (5), p.3423-3426

2001

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

Cancer, 2009-02, Vol.115 (3), p.551-560

2009

Link zum Volltext

Verfügbarkeit prüfen

Functional Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations and Potential Implications for EGFR Targeted Therapy

Clinical cancer research, 2009-01, Vol.15 (2), p.460-467

2009

Link zum Volltext

Verfügbarkeit prüfen

FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model

Blood, 2005-06, Vol.105 (12), p.4792-4799

2005

Link zum Volltext

Verfügbarkeit prüfen

Histone Deacetylase Inhibitors Induce a Very Broad, Pleiotropic Anticancer Drug Resistance Phenotype in Acute Myeloid Leukemia Cells by Modulation of Multiple ABC Transporter Genes

Clinical cancer research, 2009-06, Vol.15 (11), p.3705-3715

2009

Link zum Volltext

Verfügbarkeit prüfen

Sensitivity toward tyrosine kinase inhibitors varies between different activating mutations of the FLT3 receptor

Blood, 2003-07, Vol.102 (2), p.646-651

2003

Link zum Volltext

Verfügbarkeit prüfen

ADAM17 Regulates Epidermal Growth Factor Receptor Expression through the Activation of Notch1 in Non-Small Cell Lung Cancer

Cancer research (Chicago, Ill.), 2010-07, Vol.70 (13), p.5368-5378

2010

Link zum Volltext

Verfügbarkeit prüfen

Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells

Blood, 2000-02, Vol.95 (3), p.999-1006

2000

Link zum Volltext

Verfügbarkeit prüfen

Bcr-Abl resistance screening predicts a limited spectrum of point mutations to be associated with clinical resistance to the Abl kinase inhibitor nilotinib (AMN107)

Blood, 2006-08, Vol.108 (4), p.1328-1333

2006

Link zum Volltext

Verfügbarkeit prüfen

Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cδ

Blood, 2002-11, Vol.100 (10), p.3741-3748

2002

Link zum Volltext

Verfügbarkeit prüfen

The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletion

Haematologica (Roma), 2012-05, Vol.97 (5), p.771-779

2012

Link zum Volltext

Verfügbarkeit prüfen

Sequential Inhibitor Therapy in CML: In Vitro Simulation Elucidates the Pattern of Resistance Mutations after Second- and Third-Line Treatment

Clinical cancer research, 2013-06, Vol.19 (11), p.2962-2972

2013

Link zum Volltext

Verfügbarkeit prüfen

SRC is a signaling mediator in FLT3-ITD– but not in FLT3-TKD–positive AML

Blood, 2012-04, Vol.119 (17), p.4026-4033

2012

Link zum Volltext

Verfügbarkeit prüfen

Nucleophosmin–anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway

Blood, 2000-12, Vol.96 (13), p.4319-4327

2000

Link zum Volltext

Verfügbarkeit prüfen

FMS-Like Tyrosine Kinase 3―Internal Tandem Duplication Tyrosine Kinase Inhibitors Display a Nonoverlapping Profile of Resistance Mutations In vitro

Cancer research (Chicago, Ill.), 2009-04, Vol.69 (7), p.3032-3041

2009

Link zum Volltext

Verfügbarkeit prüfen

The Virulence Regulator Agr Controls the Staphylococcal Capacity to Activate Human Neutrophils via the Formyl Peptide Receptor 2

Journal of innate immunity, 2012-02, Vol.4 (2), p.201-212

2012

Link zum Volltext

Verfügbarkeit prüfen

How can we reduce the number of coroner autopsies? Lessons from Scotland and the Dundee initiative

Journal of the Royal Society of Medicine, 2011-01, Vol.104 (1), p.19-24

2011

Link zum Volltext

Verfügbarkeit prüfen

Formylated Peptides Are Important Virulence Factors in Staphylococcus aureus Arthritis in Mice

The Journal of infectious diseases, 2012-01, Vol.205 (2), p.305-311

2012

Link zum Volltext

Verfügbarkeit prüfen

Imatinib and leptomycin B are effective in overcoming imatinib-resistance due to Bcr-Abl amplification and clonal evolution but not due to Bcr-Abl kinase domain mutation

Haematologica (Roma), 2008-11, Vol.93 (11), p.1718-1722

2008

Link zum Volltext

Verfügbarkeit prüfen

FLT-PET Is Superior to FDG-PET for Very Early Response Prediction in NPM-ALK-Positive Lymphoma Treated with Targeted Therapy

Cancer research (Chicago, Ill.), 2012-10, Vol.72 (19), p.5014-5024

2012

Link zum Volltext

Verfügbarkeit prüfen

Antihuman epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab enhances cytolytic activity of class I-restricted HER2-specific T lymphocytes against HER2-overexpressing tumor cells

Cancer research (Chicago, Ill.), 2002-04, Vol.62 (8), p.2244-2247

2002

Link zum Volltext

Verfügbarkeit prüfen

A cell-based screen for resistance of Bcr-Abl-positive leukemia identifies the mutation pattern for PD166326, an alternative Abl kinase inhibitor

Blood, 2005-02, Vol.105 (4), p.1652-1659

2005

Link zum Volltext

Verfügbarkeit prüfen

GM1 Expression of Non-Hodgkin's Lymphoma Determines Susceptibility to Rituximab Treatment

Cancer research (Chicago, Ill.), 2008-07, Vol.68 (13), p.5414-5422

2008

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of wild-type and mutant Bcr-Abl by pyrido-pyrimidine-type small molecule kinase inhibitors

Cancer research (Chicago, Ill.), 2003-10, Vol.63 (19), p.6395-6404

2003

Link zum Volltext

Verfügbarkeit prüfen

Controlling Fibroblast Adhesion with Ph Modified Polyelectrolyte Multilayers

International journal of artificial organs, 2011-02, Vol.34 (2), p.185-191

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

ThemaMale

KollektionPublisher website

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(37)
Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Humans
(25)
Hematologic And Hematopoietic Diseases
(19)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(18)
Animals
(16)
Mice
(15)
Pharmacology. Drug Treatments
(14)
Antineoplastic Agents
(13)
Hematology
(12)
Oncology
(12)
Cell Line, Tumor
(8)
Tumors
(8)
Immunology
(7)
Female
(6)
Imatinib Mesylate
(6)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Genetics
(6)
Mutation
(6)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(14)
Cancer Research
(7)
Cancer
(3)
Clinical Cancer Research
(3)
Haematologica
(2)
The Journal Of Infectious Diseases
(2)
Drugs
(1)
Infection And Immunity
(1)
International Journal Of Artificial Organs
(1)
Journal Of Innate Immunity
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Key role of teichoic acid net charge in Staphylococcus aureus colonization of artificial surfaces

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

Functional Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations and Potential Implications for EGFR Targeted Therapy

FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model

Histone Deacetylase Inhibitors Induce a Very Broad, Pleiotropic Anticancer Drug Resistance Phenotype in Acute Myeloid Leukemia Cells by Modulation of Multiple ABC Transporter Genes

Sensitivity toward tyrosine kinase inhibitors varies between different activating mutations of the FLT3 receptor

ADAM17 Regulates Epidermal Growth Factor Receptor Expression through the Activation of Notch1 in Non-Small Cell Lung Cancer

Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells

Bcr-Abl resistance screening predicts a limited spectrum of point mutations to be associated with clinical resistance to the Abl kinase inhibitor nilotinib (AMN107)

Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cδ

The cytotoxicity of anti-CD22 immunotoxin is enhanced by bryostatin 1 in B-cell lymphomas through CD22 upregulation and PKC-βII depletion

Sequential Inhibitor Therapy in CML: In Vitro Simulation Elucidates the Pattern of Resistance Mutations after Second- and Third-Line Treatment

SRC is a signaling mediator in FLT3-ITD– but not in FLT3-TKD–positive AML

Nucleophosmin–anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway

FMS-Like Tyrosine Kinase 3―Internal Tandem Duplication Tyrosine Kinase Inhibitors Display a Nonoverlapping Profile of Resistance Mutations In vitro

The Virulence Regulator Agr Controls the Staphylococcal Capacity to Activate Human Neutrophils via the Formyl Peptide Receptor 2

How can we reduce the number of coroner autopsies? Lessons from Scotland and the Dundee initiative

Formylated Peptides Are Important Virulence Factors in Staphylococcus aureus Arthritis in Mice

Imatinib and leptomycin B are effective in overcoming imatinib-resistance due to Bcr-Abl amplification and clonal evolution but not due to Bcr-Abl kinase domain mutation

FLT-PET Is Superior to FDG-PET for Very Early Response Prediction in NPM-ALK-Positive Lymphoma Treated with Targeted Therapy

Antihuman epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab enhances cytolytic activity of class I-restricted HER2-specific T lymphocytes against HER2-overexpressing tumor cells

A cell-based screen for resistance of Bcr-Abl-positive leukemia identifies the mutation pattern for PD166326, an alternative Abl kinase inhibitor

GM1 Expression of Non-Hodgkin's Lymphoma Determines Susceptibility to Rituximab Treatment

Inhibition of wild-type and mutant Bcr-Abl by pyrido-pyrimidine-type small molecule kinase inhibitors

Controlling Fibroblast Adhesion with Ph Modified Polyelectrolyte Multilayers

Aktive Filter

Suchergebnisse filtern